B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67% Market Closed
Market Cap: 378.5m PLN

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BML.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BML Intrinsic Value
Not Available
Base Case Scenario
Compare BML to

Fundamental Analysis

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BML?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biomed Lublin Wytwornia Surowic i Szczepionek SA

Current Assets 54.2m
Cash & Short-Term Investments 24.7m
Receivables 14m
Other Current Assets 15.4m
Non-Current Assets 119.4m
Long-Term Investments 4.3m
PP&E 109m
Intangibles 404k
Other Non-Current Assets 5.7m
Current Liabilities 27.3m
Accounts Payable 16.5m
Accrued Liabilities 3.9m
Other Current Liabilities 6.9m
Non-Current Liabilities 40m
Long-Term Debt 8.4m
Other Non-Current Liabilities 31.6m
Efficiency

Free Cash Flow Analysis
Biomed Lublin Wytwornia Surowic i Szczepionek SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biomed Lublin Wytwornia Surowic i Szczepionek SA

Revenue
53.8m PLN
Cost of Revenue
-23.2m PLN
Gross Profit
30.6m PLN
Operating Expenses
-18.7m PLN
Operating Income
11.8m PLN
Other Expenses
-4.2m PLN
Net Income
7.6m PLN
Fundamental Scores

BML Profitability Score
Profitability Due Diligence

Biomed Lublin Wytwornia Surowic i Szczepionek SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Healthy Operating Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Biomed Lublin Wytwornia Surowic i Szczepionek SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BML Solvency Score
Solvency Due Diligence

Biomed Lublin Wytwornia Surowic i Szczepionek SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

hidden
Solvency
Score

Biomed Lublin Wytwornia Surowic i Szczepionek SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BML Price Targets Summary
Biomed Lublin Wytwornia Surowic i Szczepionek SA

There are no price targets for BML.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BML is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y